Matrix-metalloprotease (MMP)-sensitive hydrogel particles intend to utilize the unique properties of tumor cells, such as high concentration of MMP enzymes, along with the synergistic activities of an apoptosis-inducing protein (TRAIL) and the TRAIL sensitizer drug Quinacrine.
